A bivalent B-cell epitope dendrimer peptide can confer long-lasting immunity in swine against foot-and-mouth disease.
Animals
Antibodies, Neutralizing
Antibodies, Viral
/ immunology
Dendrimers
Epitopes, B-Lymphocyte
/ immunology
Epitopes, T-Lymphocyte
/ immunology
Female
Foot-and-Mouth Disease
/ immunology
Foot-and-Mouth Disease Virus
/ immunology
Immunity
Neutralization Tests
Peptides
/ immunology
Swine
Swine Diseases
/ immunology
T-Lymphocytes
/ immunology
Viral Vaccines
/ administration & dosage
FMDV
dendrimer peptide
protection
swine
vaccine
Journal
Transboundary and emerging diseases
ISSN: 1865-1682
Titre abrégé: Transbound Emerg Dis
Pays: Germany
ID NLM: 101319538
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
24
10
2019
revised:
05
12
2019
accepted:
20
01
2020
pubmed:
30
1
2020
medline:
18
7
2020
entrez:
30
1
2020
Statut:
ppublish
Résumé
Foot-and-mouth disease virus (FMDV) causes a widely extended contagious disease of livestock. We have previously reported that a synthetic dendrimeric peptide, termed B
Substances chimiques
Antibodies, Neutralizing
0
Antibodies, Viral
0
Dendrimers
0
Epitopes, B-Lymphocyte
0
Epitopes, T-Lymphocyte
0
Peptides
0
Viral Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1614-1622Subventions
Organisme : Spanish Ministry of Science, Innovation and Universities
ID : AGL2014-52395-C2
Organisme : Spanish Ministry of Science, Innovation and Universities
ID : AGL2016-76445-R
Organisme : Spanish Ministry of Science, Innovation and Universities
ID : AGL2017-89097-C2
Organisme : Comunidad de Madrid
ID : P2018/BAA-4370-PLATESA 2
Organisme : Comunidad de Madrid
ID : S2013/ABI-2906-PLATESA
Organisme : Generalitat de Catalunya
ID : 2009SGR492
Informations de copyright
© 2020 Blackwell Verlag GmbH.
Références
Acharya, R., Fry, E., Stuart, D., Fox, G., Rowlands, D., & Brown, F. (1989). The three-dimensional structure of foot-and-mouth disease virus at 2.9 A resolution. Nature, 337(6209), 709-716.
Bittle, J. L., Houghten, R. A., Alexander, H., Shinnick, T. M., Sutcliffe, J. G., Lerner, R. A., … Brown, F. (1982). Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature, 298(5869), 30-33.
Blanco, E., Andreu, D., & Sobrino, F. (2017). Advantages, challenges and future of peptide vacines. In F. Sobrino, & E. Domingo (Eds.), Foot-and-mouth diseasae virus. Current reserach and emerging trends (pp. 317-331). Norfolk, UK: Caister Academic Press.
Blanco, E., Garcia-Briones, M., Sanz-Parra, A., Gomes, P., De Oliveira, E., Valero, M. L., … Sobrino, F. (2001). Identification of T-cell epitopes in nonstructural proteins of foot-and-mouth disease virus. Journal of Virology, 75(7), 3164-3174. https://doi.org/10.1128/JVI.75.7.3164-3174.2001
Blanco, E., Guerra, B., de la Torre, B. G., Defaus, S., Dekker, A., Andreu, D., & Sobrino, F. (2016). Full protection of swine against foot-and-mouth disease by a bivalent B-cell epitope dendrimer peptide. Antiviral Research, 129, 74-80. https://doi.org/10.1016/j.antiviral.2016.03.005
Borrego, B., Blanco, E., Rodriguez Pulido, M., Mateos, F., Lorenzo, G., Cardillo, S., … Saiz, M. (2017). Combined administration of synthetic RNA and a conventional vaccine improves immune responses and protection against foot-and-mouth disease virus in swine. Antiviral Research, 142, 30-36. https://doi.org/10.1016/j.antiviral.2017.03.009
Borrego, B., Rodriguez-Pulido, M., Mateos, F., de la Losa, N., Sobrino, F., & Saiz, M. (2013). Delivery of synthetic RNA can enhance the immunogenicity of vaccines against foot-and-mouth disease virus (FMDV) in mice. Vaccine, 31(40), 4375-4381. https://doi.org/10.1016/j.vaccine.2013.07.008
Borrego, B., Rodriguez-Pulido, M., Revilla, C., Alvarez, B., Sobrino, F., Dominguez, J., & Saiz, M. (2015). Synthetic RNAs mimicking structural domains in the foot-and-mouth disease virus genome elicit a broad innate immune response in porcine cells triggered by RIG-I and TLR activation. Viruses, 7(7), 3954-3973. https://doi.org/10.3390/v7072807
Brun, A., Barcena, J., Blanco, E., Borrego, B., Dory, D., Escribano, J. M., … Dixon, L. K. (2011). Current strategies for subunit and genetic viral veterinary vaccine development. Virus Research, 157(1), 1-12. https://doi.org/10.1016/j.virusres.2011.02.006
Cox, S. J., Aggarwal, N., Statham, R. J., & Barnett, P. V. (2003). Longevity of antibody and cytokine responses following vaccination with high potency emergency FMD vaccines. Vaccine, 21(13-14), 1336-1347. https://doi.org/10.1016/S0264-410X(02)00691-6
Cubillos, C., de la Torre, B. G., Jakab, A., Clementi, G., Borras, E., Barcena, J., … Blanco, E. (2008). Enhanced mucosal immunoglobulin A response and solid protection against foot-and-mouth disease virus challenge induced by a novel dendrimeric peptide. Journal of Virology, 82(14), 7223-7230. https://doi.org/10.1128/JVI.00401-08
Curiel, R. E., Mason, K. M., Dryden, T. D., Maurer, M. J., & Bigley, N. J. (1998). Cytokines produced early in picornavirus infection reflect resistance or susceptibility to disease. Journal of Interferon & Cytokine Research, 18(8), 587-596. https://doi.org/10.1089/jir.1998.18.587
Doel, T. R. (2005). Natural and vaccine induced immunity to FMD. Current Topics in Microbiology and Immunology, 288, 103-131.
Domingo, E., Baranowski, E., Escarmis, C., & Sobrino, F. (2002). Foot-and-mouth disease virus. Comparative Immunology, Microbiology and Infectious Diseases, 25(5-6), 297-308. https://doi.org/10.1016/S0147-9571(02)00027-9
Garcia-Briones, M. M., Blanco, E., Chiva, C., Andreu, D., Ley, V., & Sobrino, F. (2004). Immunogenicity and T cell recognition in swine of foot-and-mouth disease virus polymerase 3D. Virology, 322(2), 264-275. https://doi.org/10.1016/j.virol.2004.01.027
Grubman, M. J., & Baxt, B. (2004). Foot-and-mouth disease. Clinical Microbiology Reviews, 17(2), 465-493. https://doi.org/10.1128/CMR.17.2.465-493.2004
Lee, H. B., Piao, D. C., Lee, J. Y., Choi, J. Y., Bok, J. D., Cho, C. S., … Choi, Y. J. (2017). Artificially designed recombinant protein composed of multiple epitopes of foot-and-mouth disease virus as a vaccine candidate. Microbial Cell Factories, 16(1), 33. https://doi.org/10.1186/s12934-017-0648-2
McCullough, K. C., Bruckner, L., Schaffner, R., Fraefel, W., Muller, H. K., & Kihm, U. (1992). Relationship between the anti-FMD virus antibody reaction as measured by different assays, and protection in vivo against challenge infection. Veterinary Microbiology, 30(2-3), 99-112. https://doi.org/10.1016/0378-1135(92)90106-4
Monso, M., de la Torre, B. G., Blanco, E., Moreno, N., & Andreu, D. (2013). Influence of conjugation chemistry and B epitope orientation on the immune response of branched peptide antigens. Bioconjugate Chemistry, 24(4), 578-585. https://doi.org/10.1021/bc300515t
Pfaff, E., Mussgay, M., Bohm, H. O., Schulz, G. E., & Schaller, H. (1982). Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus. The EMBO Journal, 1(7), 869-874. https://doi.org/10.1002/j.1460-2075.1982.tb01262.x
Purcell, A. W., McCluskey, J., & Rossjohn, J. (2007). More than one reason to rethink the use of peptides in vaccine design. Nature Reviews Drug Discovery, 6(5), 404-414. https://doi.org/10.1038/nrd2224
Robinson, L., Knight-Jones, T. J., Charleston, B., Rodriguez, L. L., Gay, C. G., Sumption, K. J., & Vosloo, W. (2016). Global Foot-and-Mouth Disease Research Update and Gap Analysis: 3 - Vaccines. Transboundary and Emerging Diseases, 63(Suppl 1), 30-41. https://doi.org/10.1111/tbed.12521
Rodriguez, L. L., & Grubman, M. J. (2009). Foot and mouth disease virus vaccines. Vaccine, 27(Suppl 4), D90-D94. https://doi.org/10.1016/j.vaccine.2009.08.039
Rodriguez-Pulido, M., Borrego, B., Sobrino, F., & Saiz, M. (2011). RNA structural domains in noncoding regions of the foot-and-mouth disease virus genome trigger innate immunity in porcine cells and mice. Journal of Virology, 85(13), 6492-6501. https://doi.org/10.1128/JVI.00599-11
Rueckert, C., & Guzman, C. A. (2012). Vaccines: From empirical development to rational design. PLoS Path, 8(11), e1003001. https://doi.org/10.1371/journal.ppat.1003001
Sitt, T., Kenney, M., Barrera, J., Pandya, M., Eckstrom, K., Warner, M., … Golde, W. T. (2019). Duration of protection and humoral immunity induced by an adenovirus-vectored subunit vaccine for foot-and-mouth disease (FMD) in Holstein steers. Vaccine, 37(42), 6221-6231. https://doi.org/10.1016/j.vaccine.2019.08.017
Smitsaart, E. N., & Bergmann, I. E. (2017). Current inactivated FMD vaccines. In F. Sobrino, & E. Domingo (Eds.), Foot-and-Mouth Disease Virus. Current Research and Emerging Trends (pp. 287-316). Norfolk, UK: Caister Academic Press.
Sumption, K., Rweyemamu, M., & Wint, W. (2008). Incidence and distribution of foot-and-mouth disease in Asia, Africa and South America; combining expert opinion, official disease information and livestock populations to assist risk assessment. Transboundary and Emerging Diseases, 55(1), 5-13. https://doi.org/10.1111/j.1865-1682.2007.01017.x
Taboga, O., Tami, C., Carrillo, E., Nunez, J. I., Rodriguez, A., Saiz, J. C., … Palma, E. L. (1997). A large-scale evaluation of peptide vaccines against foot-and-mouth disease: Lack of solid protection in cattle and isolation of escape mutants. Journal of Virology, 71(4), 2606-2614. https://doi.org/10.1128/JVI.71.4.2606-2614.1997
Tam, J. P. (1988). Synthetic peptide vaccine design: Synthesis and properties of a high-density multiple antigenic peptide system. Proceedings of the National Academy of Sciences of the United States of America, 85(15), 5409-5413. https://doi.org/10.1073/pnas.85.15.5409
Wu, Q., Brum, M. C., Caron, L., Koster, M., & Grubman, M. J. (2003). Adenovirus-mediated type I interferon expression delays and reduces disease signs in cattle challenged with foot-and-mouth disease virus. Journal of Interferon & Cytokine Research, 23(7), 359-368. https://doi.org/10.1089/107999003322226014